Elypta

📍 Solna, Sweden🗓 Founded 2017👥 26 employees💰 Last funded Jan 2020
Biotechnology Research🌐 elypta.com
Website LinkedIn
Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome – system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer noninvasively. Elypta is advancing a broad clinical program across different cancers with the first indication expected to be early detection of recurrence in renal cell carcinoma. Several years of research in Nielsen lab at Chalmers University of Technology in Gothenburg, Sweden led to the founding of Elypta in May 2017 by Francesco Gatto and Jens Nielsen.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
3
Investor activity2017–2020 · investors recorded per year
201712019120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Elypta?
Elypta has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Elypta last raise funding?
The most recent investment in Elypta recorded on gritt.io was in January 2020.
When was Elypta founded?
Elypta was founded in 2017.
What industry is Elypta in?
Elypta operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Elypta based?
Elypta is headquartered in Solna, Sweden.